Evidence map›Paper›PMID 20004149›Full record

ArticleDNA repair2010

Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.

Adam S Mastrocola, Christopher D Heinen

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  3. Article
  4. Article
  5. Review
  6. Overview for the histone codes for DNA repair.Progress in molecular biology and translational science · 2012
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adam S MastrocolaNeag Comprehensive Cancer Center and Center for Molecular Medicine, University of Connecticut Health Center, 263 Farmington Avenue, ML3101, Farmington, CT 06030-3101, USA.
Christopher D Heinen
UConn Health · US

Funding

Mismatch Repair Functions Affected During TumorigenesisR01CA115783 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HEINEN, CHRISTOPHER D. · 2008 to 2012
$1.2M
NCI NIH HHS CA115783NCI NIH HHS R01 CA115783
6 · The paper itself

Abstract

The DNA mismatch repair (MMR) system is highly conserved and vital for preserving genomic integrity. Current mechanistic models for MMR are mainly derived from in vitro assays including reconstitution of strand-specific MMR and DNA binding assays using short oligonucleotides. However, fundamental questions regarding the mechanism and regulation in the context of cellular DNA replication remain. Using synchronized populations of HeLa cells we demonstrated that hMSH2, hMLH1 and PCNA localize to the chromatin during S-phase, and accumulate to a greater extent in cells treated with a DNA alkylating agent. In addition, using small interfering RNA to deplete hMSH2, we demonstrated that hMLH1 localization to the chromatin is hMSH2-dependent. hMSH2/hMLH1/PCNA proteins, when associated with the chromatin, form a complex that is greatly enhanced by DNA damage. The DNA damage caused by high doses of alkylating agents leads to a G(2) arrest after only one round of replication. In these G(2)-arrested cells, an hMSH2/hMLH1 complex persists on chromatin, however, PCNA is no longer in the complex. Cells treated with a lower dose of alkylating agent require two rounds of replication before cells arrest in G(2). In the first S-phase, the MMR proteins form a complex with PCNA, however, during the second S-phase PCNA is missing from that complex. The distinction between these complexes may suggest separate functions for the MMR proteins in damage repair and signaling. Additionally, using confocal immunofluorescence, we observed a population of hMSH6 that localized to the nucleolus. This population is significantly reduced after DNA damage suggesting that the protein is shuttled out of the nucleolus in response to damage. In contrast, hMLH1 is excluded from the nucleolus at all times. Thus, the nucleolus may act to segregate a population of hMSH2-hMSH6 from hMLH1-hPMS2 such that, in the absence of DNA damage, an inappropriate response is not invoked.

Indexed as

DNA DamageDNA Mismatch RepairAdaptor Proteins, Signal TransducingCell CycleCell NucleusChromatinDNA-Binding ProteinsFluorescent Antibody TechniqueHeLa CellsHumansMethylnitronitrosoguanidineMicroscopy, ConfocalMutL Protein Homolog 1MutS Homolog 2 ProteinNuclear ProteinsProliferating Cell Nuclear AntigenAdaptor Proteins, Signal TransducingChromatinDNA-Binding ProteinsG-T mismatch-binding proteinMethylnitronitrosoguanidineMLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 ProteinNuclear ProteinsProliferating Cell Nuclear Antigen

Identifiers

PMID20004149
PMCPMC2819642
OpenAlexW2005363422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.